sorafenib has been researched along with trifluridine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (trifluridine) | Trials (trifluridine) | Recent Studies (post-2010) (trifluridine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 746 | 121 | 351 |
| Protein | Taxonomy | sorafenib (IC50) | trifluridine (IC50) |
|---|---|---|---|
| Thymidine kinase | Macacine alphaherpesvirus 1 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Peedell, C; Polwart, C; Wadd, N | 1 |
2 other study(ies) available for sorafenib and trifluridine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Real-World Assessment of Cancer Drugs Using Local Data Uploaded to the Systemic Anti-Cancer Therapy Dataset in England.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Humans; Paclitaxel; Pancreatic Neoplasms; Sorafenib; State Medicine; Trifluridine | 2022 |